Forget Nvidia FOMO: 8 Underdog Stocks With Greater Earnings Growth Potential

 | Feb 26, 2024 08:59

  • Investor sentiment remains bullish (44.3%) and remains above its historical average (37.5%) for another week.
  • While Nvidia is soaring, other stocks could register bigger gains this year.
  • In this piece, we'll take a look at those stocks and also how one can invest in the magnificent 7 through various funds.
  • Investing in the stock market? Take advantage of our InvestingPro discounts . More information at the end of this article.

    • The technology sector has been a key driver of the S&P 500's strength, led by the Magnificent 7.

    Nvidia (NASDAQ:NVDA) has stood out among the Magnificent 7, not just as the biggest gainer, but also in terms of the wide margin by which it beat other major stocks' performance.

    After all seven companies presented results, the comparison is striking.

    The other six stocks saw an average revenue increase of +15% (Apple (NASDAQ:AAPL) +2%, Meta (NASDAQ:META) +25%), while Nvidia boasted an impressive +265%.

    Will the chipmaker continue to post staggering gains? Only time will tell. However, as investors, we should keep an eye out for alternative stocks that could perform even better this year.

    While Nvidia has stolen all the headlines, over the past four years, some stocks have outperformed even Nvidia's +963% growth since February 19, 2020.

    Examples include Celsius (NASDAQ:CELH) (+3,030%), Antero Resources (NYSE:AR) (+1,232%), Range Resources (NYSE:RRC) (+871%), Builders FirstSource (NYSE:BLDR) (+557%), Shockwave Medical (NASDAQ:SWAV) (+514%), and EQT (NYSE:EQT) (+509%).

    Additionally, Advanced Micro Devices (NASDAQ:AMD), not part of the Magnificent 7 but noteworthy, has climbed to the 25th position in the S&P 500 and the 10th spot on the Nasdaq 100.

    Looking at the earnings growth expectations for 2024, only a select group of companies is projected to outpace Nvidia:

    1. Allstate (NYSE:ALL): An insurance company with an expected EPS increase of +1211%.
    2. Merck & Company (NYSE:MRK): A pharmaceutical and chemical giant forecasting a +466% growth, driven by drugs like Keytruda.
    3. Stanley Black & Decker (NYSE:SWK) (+184.6%)
    4. Estee Lauder (NYSE:EL) (+125.9%)
    5. Tyson Foods (NYSE:TSN) (+125.1%)
    6. Paramount Global (NASDAQ:PARA) (+115.3%)
    7. Eli Lilly and Company (NYSE:LLY) (+98%)
    8. Targa Resources (NYSE:TRGP) (+82.3%).
    h2 Should You Consider Investing in This ETF to Gain Exposure to the Magnificent 7?/h2

    The Roundhill Magnificent Seven ETF (NASDAQ:MAGS) provides exposure to the Magnificent Seven stocks.

    It started trading on April 11, 2023, under the name Roundhill BIG Tech (BIGT) and was later renamed Roundhill Magnificent Seven on November 9, 2023.